Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02810652 · ClinicalTrials.gov registry record · NA
Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 160
- Enrollment target
NCT02810652: Completed NA study, sponsored by Massachusetts General Hospital.
NCT02810652 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 160 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02810652, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
Study Summary
The purpose of this research study is to addresses the challenge of managing the unique perioperative needs of older cancer patients undergoing surgical resection.
Primary Outcome
Hospital length of stay from admission to discharge
Interventions
- OTHER Usual Care
- OTHER Perioperative Geriatrics Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2016-09 |
| Est. Completion | 2022-01 |
| Phase | NA |
What the finished NCT02810652 record still lists
NCT02810652 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT02810652 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02810652 about?
NCT02810652 is a clinical study titled "Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection". The purpose of this research study is to addresses the challenge of managing the unique perioperative needs of older cancer patients undergoing surgical resection.
What is the current status of trial NCT02810652?
This trial is currently completed. It is a NA study. The enrollment target is 160 participants. The study started on 2016-09. Estimated completion is 2022-01.
What interventions are being tested in trial NCT02810652?
The interventions under investigation include: Usual Care (OTHER), Perioperative Geriatrics Intervention (OTHER).
Who is sponsoring clinical trial NCT02810652?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02810652's enrollment target sits among peer trials
160 628th of 2000 higher than 1,347 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia